BCL2L1 and melanoma: VPA, SAHA, and TSA on several melanoma cell lines were found to allow acetylation of H3 and H4 histones, leading to an increase in DR4 and DR5 expression levels and to concomitant inhibition of Bcl-xS, Bcl-xL [132].